These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7271531)

  • 1. Dialysis treatment in schizophrenia: two years experience.
    Splendiani G; Bruno V; D'Alessandro V; Pomero P; Cammà ML; Tancredi M
    Artif Organs; 1981 May; 5(2):175-7. PubMed ID: 7271531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-year trial of dialytic treatment for schizophrenia.
    Splendiani G; Bruno V; Marinangeli G; Cupillari M; Cirelli C; Tancredi M
    Artif Organs; 1983 Aug; 7(3):322-5. PubMed ID: 6625961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-permeable membranes and hypersensitivity-like reactions: role of dialysis fluid contamination.
    Bigazzi R; Atti M; Baldari G
    Blood Purif; 1990; 8(4):190-8. PubMed ID: 2085427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficiency of different hollow-fiber hemofilters in continuous arteriovenous hemodiafiltration.
    Morabito S; Pierucci A; Marinelli R; Cicciarelli A; Guzzo I; Cinotti GA; Marino B; Chiavarelli R
    Am J Nephrol; 2000; 20(2):116-21. PubMed ID: 10773611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of vancomycin in patients undergoing hemodialysis with polyacrylonitrile.
    Torras J; Cao C; Rivas MC; Cano M; Fernandez E; Montoliu J
    Clin Nephrol; 1991 Jul; 36(1):35-41. PubMed ID: 1889149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biofiltration: an effective and simple method to reduce dialysis time.
    Mingardi G; Massazza M; Viganò G; Mecca G
    Int J Artif Organs; 1986 Dec; 9 Suppl 3():133-6. PubMed ID: 3557661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of four different high-flux hemodialyzers under conventional conditions in vivo.
    Sombolos K; Tsitamidou Z; Kyriazis G; Karagianni A; Kantaropoulou M; Progia E
    Am J Nephrol; 1997; 17(5):406-12. PubMed ID: 9382156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
    Chenoweth DE; Cheung AK; Henderson LW
    Kidney Int; 1983 Dec; 24(6):764-9. PubMed ID: 6609269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo assessment of intact parathyroid hormone adsorption by different dialysis membranes during hemodialysis.
    Balducci A; Coen G; Manni M; Perruzza I; Fassino V; Sardella D; Grandi F
    Artif Organs; 2004 Dec; 28(12):1067-75. PubMed ID: 15554934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is platelet-activating factor produced during hemodialysis with AN-69 polyacrylonitrile membrane?
    Iatrou C; Afentakis N; Nomikos T; Dinas C; Stavropoulos-Giokas C; Antonopoulou S
    Nephron; 2002 May; 91(1):86-93. PubMed ID: 12021524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the ability of hemodialysis membranes to induce, bind, and clear human interleukin-1.
    Lonnemann G; Koch KM; Shaldon S; Dinarello CA
    J Lab Clin Med; 1988 Jul; 112(1):76-86. PubMed ID: 3260615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AN69-ST membrane, a useful option in two cases of severe dialysis reactions.
    Cerqueira A; Martins PA; Carvalho BA; Vasconcelos MP
    Clin Nephrol; 2015 Feb; 83(2):100-3. PubMed ID: 25208312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaphylactoid reactions during hemodialysis on AN69 membranes in patients receiving ACE inhibitors.
    Tielemans C; Madhoun P; Lenaers M; Schandene L; Goldman M; Vanherweghem JL
    Kidney Int; 1990 Nov; 38(5):982-4. PubMed ID: 2266684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is 3000 S Hospal a suitable dialyzer to shorten dialysis time schedule? A cooperative study on biofiltration.
    Fuiano G; Memoli B; Dal Canton A; Papa A; Pacchiano G; Rampino T; Marcuccio F; Andreucci VE; Cioffi L; Martucciello L
    Int J Artif Organs; 1986 Dec; 9 Suppl 3():31-4. PubMed ID: 3557669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant renal and hepatic failure treated by polyacrylonitrile membrane hemodialysis.
    Strand V; Mayor G; Ristow G; Greenbaum D; Mayle J; Rosenbaum R
    Int J Artif Organs; 1981 May; 4(3):136-9. PubMed ID: 7275343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solute clearance in continuous venovenous hemodialysis. A comparison of cuprophane, polyacrylonitrile, and polysulfone membranes.
    Ifediora OC; Teehan BP; Sigler MH
    ASAIO J; 1992; 38(3):M697-701. PubMed ID: 1457952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of bradykinin in anaphylactoid reactions during hemodialysis with AN69 dialyzers.
    Schaefer RM; Fink E; Schaefer L; Barkhausen R; Kulzer P; Heidland A
    Am J Nephrol; 1993; 13(6):473-7. PubMed ID: 8141183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of acute leukopenia in hemodialysis. Role of direct leukocyte and dialyzer membrane interaction].
    Pacitti A; Segoloni G; Triolo G; Tetta C; Messina M; Bussolino F; Camussi G; Ragni R; Martini PF; Coppo R; Vercellone A
    Minerva Nefrol; 1980; 27(4):651-3. PubMed ID: 7254693
    [No Abstract]   [Full Text] [Related]  

  • 19. Patient survival on PAN/AN 69 membrane hemodialysis.
    Chanard J
    J Am Soc Nephrol; 1994 Jun; 4(12):2050-1. PubMed ID: 7919158
    [No Abstract]   [Full Text] [Related]  

  • 20. Phagocytic activity of leukocytes induced by different dialyzer membranes.
    Vanholder R; Dhondt A; Van Landschoot N; Waterloos MA; Ringoir S
    Contrib Nephrol; 1989; 74():86-90. PubMed ID: 2518453
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.